All In Biotech

Drug Trial Radar · NCT06400004

Lumason® Infusion vs. Bolus Administrations

A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 106 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

106

Planned (sponsor's estimate)

Start

Jul 10, 2024

Primary completion

Aug 29, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Bracco Diagnostics, IncIndustry
Sponsor type
Industry
First posted
May 6, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Crossover
Masking
Single (outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).

Conditions

  • Heart Diseases

Interventions

  • Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]Drug

    Bolus administration of 2 mL undiluted Lumason®, to be administered in 20 seconds

  • LumasonDrug

    Continuous infusion of 8 mL of diluted Lumason® (4 mL of Lumason® diluted in 4 mL of saline) at a rate of 1.0 mL/min

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adequate LV EBD ScoreTime frame: 2-3 Hours
  2. Adequate LV OpacificationTime frame: 2-3 Hours

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Interventional Cardiology Medical Group

    West Hills, California · Recruiting

  • Piedmont Heart Institute

    Atlanta, Georgia · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • Oregon Health and Sciences University

    Portland, Oregon · Not yet recruiting

  • University of Texas Medical Branch

    Galveston, Texas · Withdrawn

  • Vital Heart and Vein

    Humble, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.